Clinical trials

  • PM534 for Advanced solid tumors
  • PSILOCYBINE for Treatment-resistant depression
  • RECOMBINANT HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 FUSED TO THE FC FRAGMENT OF IGG1 for Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) deficiency | ABCC6 deficiency | Generalized arterial calcification of infancy (GACI) | Pseudoxanthoma elasticum (PXE)
  • RO7790121 for Moderately to severely active Crohn's disease
  • NIVOLUMAB for Nasopharyngeal cancer
  • RAPCABTAGENE AUTOLEUCEL for Relapsing multiple sclerosis
  • darbepoetin alfa for Perinatal arterial ischemic stroke (PAIS) | Ischemic neonatal stroke
  • OVX033 for Coronavirus infection | Sarbecoviruses disease
  • OBEXELIMAB for Relapsing multiple sclerosis | Relapsing-remitting multiple sclerosis | Secondary progressive multiple sclerosis (active)
  • CRIZOTINIB for Neurofibromatosis type 2
  • DURVALUMAB for Non-small cell lung cancer (resectable stage IIIA–IIIB)
  • ONFEKAFUSP ALFA for Unresectable and/or metastatic soft tissue sarcoma